The robotic assisted endovascular systems market size is projected to be worth USD 94.0 million in 2023. The market is likely to surpass USD 214.7 million by 2033 at a CAGR of 8.6% during the forecast period.
The robotic assisted endovascular systems market refers to the market that involves the use of robotic technology in endovascular procedures. Endovascular procedures are minimally invasive procedures performed inside blood vessels, typically to treat conditions such as cardiovascular diseases, peripheral artery diseases, aneurysms, and other vascular disorders.
Other Drivers Propelling the Demand for Robotic Assisted Endovascular Systems include:
Challenges for Companies /Manufacturers in the Robotic Assisted Endovascular Systems Market:
Opportunities in the Robotic Assisted Endovascular Systems Industry:
Latest Trends in the Robotic Assisted Endovascular Systems Market:
| Attributes | Details |
|---|---|
| Robotic Assisted Endovascular Systems Market Size (2023) | USD 94.0 million |
| Robotic Assisted Endovascular Systems Market Projected Size (2033) | USD 214.7 million |
| Value CAGR (2023 to 2033) | 8.6% |
From 2017 to 2022, the global robotic assisted endovascular systems market experienced a CAGR of 6.5%, reaching a market size of USD 94.0 million in 2023.
From 2017 to 2022, robotic technology began to make its way into the field of endovascular interventions. The first generation of Robotic Assisted Endovascular Systems was introduced, offering improved precision and control during procedures. These early systems primarily focused on cardiovascular interventions, such as percutaneous coronary interventions (PCI) and transcatheter aortic valve replacement (TAVR).
As the technology advanced, more sophisticated robotic systems entered the market, incorporating features such as enhanced imaging capabilities, better ergonomics, and increased automation. The market expanded beyond cardiovascular procedures to include peripheral vascular interventions, such as treating peripheral artery disease (PAD) and performing endovascular aneurysm repair (EVAR).
Future Forecast for Robotic Assisted Endovascular Systems Industry:
Looking ahead, the global robotic assisted endovascular systems industry is expected to rise at a CAGR of 8.6% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 214.7 million by 2033.
The robotic assisted endovascular systems industry is expected to continue its growth trajectory from 2023 to 2033, driven by increasing adoption of advanced robotic assisted endovascular systems that offers higher efficiency and precision during endovascular procedures. Also, the growing demand for innovative, minimally invasive surgical procedures which reduce patient trauma and recovery time will drive the market’s growth.
| Country | The United States |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 135.9 million |
| CAGR % 2023 to End of Forecast (2033) | 9.6% |
The robotic assisted endovascular systems industry in the United States is expected to reach a market size of USD 135.9 million by 2033, expanding at a CAGR of 9.6%.
The United States has a significant burden of cardiovascular and peripheral vascular diseases, including conditions such as coronary artery disease, peripheral artery disease, and aortic aneurysms. The rising prevalence of these diseases is driving the demand for advanced technologies like Robotic Assisted Endovascular Systems that can improve procedural outcomes and patient care.
| Country | The United Kingdom |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 12.0 million |
| CAGR % 2023 to End of Forecast (2033) | 7.9% |
The robotic assisted endovascular systems industry in the United Kingdom is expected to reach a market value of USD 12.0 million, expanding at a CAGR of 7.9% during the forecast period. Surgeons in the UK are increasingly recognizing the benefits of robotic assistance in endovascular procedures.
Robotic systems provide enhanced precision, stability, and control, resulting in improved procedural outcomes, reduced complications, and shorter recovery times for patients. Surgeon demand for these advantages is driving the adoption of Robotic Assisted Endovascular Systems.
| Country | China |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 4.9 million |
| CAGR % 2023 to End of Forecast (2033) | 6.8% |
The robotic assisted endovascular systems industry in China is anticipated to reach a market size of USD 4.9 million, moving at a CAGR of 6.8% during the forecast period. Increasing healthcare expenditure in China and expanding insurance coverage have made advanced medical technologies more accessible to patients.
This includes coverage for robotic-assisted procedures, incentivizing healthcare providers to invest in Robotic Assisted Endovascular Systems. The availability of insurance coverage for these procedures is contributing to the market growth in China.
| Country | Japan |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 7.5 million |
| CAGR % 2023 to End of Forecast (2033) | 8.6% |
The robotic assisted endovascular systems industry in Japan is estimated to reach a market size of USD 7.5 million by 2033, thriving at a CAGR of 8.6%. Collaboration between international robotic system manufacturers and Japanese healthcare institutions is playing a significant role in driving the growth of the market. These collaborations focus on technology transfer, research and development, clinical trials, and training programs to promote the adoption and utilization of Robotic Assisted Endovascular Systems in Japan.
| Country | South Korea |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 2.1 million |
| CAGR % 2023 to End of Forecast (2033) | 4.8% |
The robotic assisted endovascular systems industry in South Korea is expected to reach a market size of USD 2.1 million, expanding at a CAGR of 4.8% during the forecast period. Patients in South Korea are becoming more aware of and demanding advanced treatment options.
They seek minimally invasive procedures that offer faster recovery, reduced pain, and improved quality of life compared to traditional open surgeries. Robotic Assisted Endovascular Systems enable minimally invasive interventions, making them appealing to patients and contributing to the growth of the market.
The systems is expected to dominate the robotic assisted endovascular systems industry with a CAGR of 8.8% from 2023 to 2033. They are transforming the way in which medical procedures are performed.
These systems are contributing to the growth of this market in many ways as they allow for increased accuracy, faster procedures, and less invasive surgeries.
Endovascular operations are streamlined using robotic equipment, which give surgeons exquisite control and dexterity. They can help with activities including catheter manipulation, guidewire setting, and suturing, which improves the effectiveness of the procedures and cuts down on the time needed to complete them.
The percutaneous coronary intervention application segments are expected to dominate the robotic assisted endovascular systems industry with a CAGR of 9.9% from 2023 to 2033. This segment captures a significant market share in 2023. By unblocking or widening restricted coronary arteries, percutaneous coronary intervention is a minimally invasive treatment used to treat coronary artery disease.
Because it is less invasive than conventional open-heart operations, it has grown in popularity. The need for cutting-edge technology like RAES to further enhance procedural results and patient experience has been fueled by the desire for minimally invasive therapies like percutaneous coronary intervention.
The hospital segment is expected to dominate the robotic assisted endovascular systems industry with a CAGR of 9.0% from 2023 to 2033. Hospitals are leading the way in embracing and putting innovative medical technologies into practice. Hospitals understand the value of integrating robotic-assisted endovascular systems into their facilities because these systems improve precision, accuracy, and patient outcomes. Their investment in RAES technology stimulates demand for these systems, which expands the market.
The robotic assisted endovascular systems withdrawal device sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
Product Development
To produce novel products that increase effectiveness, dependability, and affordability, businesses make substantial expenditures in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Strategic Alliances & Collaborations
Strategic partnerships and alliances with other companies are frequently formed by significant players in an industry to take benefit from each other's advantages and expand their market reach. Through such partnerships, businesses may also obtain access to new technologies and markets.
Expansion into Emerging Markets
In emerging economies like China as well as India, the robotic assisted endovascular systems removal device business is rising significantly. To boost their presence in these regions, major companies are expanding their supply chains and building regional manufacturing sites.
Acquisitions and mergers
Leading companies in the robotic assisted endovascular systems withdrawal devices industry routinely use mergers and acquisitions to bolster their market positions, broaden their product offerings, and enter new markets.
Key Developments in the Robotic Assisted Endovascular Systems Market:
The market is valued at USD 94.0 million in 2023.
Key players include Siemens Healthcare, Stereotaxis Inc., and more.
Hospitals and labs are key consumers of these systems.
The market is likely to surpass USD 214.7 million by 2033.
Trends include AI integration, miniaturization, and collaborative robotics.
Explore Therapeutic Device Insights
Robotic Assisted Endovascular Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
